Your browser doesn't support javascript.
loading
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients.
Kasanen, Henna; Hernberg, Micaela; Mäkelä, Siru; Brück, Oscar; Juteau, Susanna; Kohtamäki, Laura; Ilander, Mette; Mustjoki, Satu; Kreutzman, Anna.
Afiliação
  • Kasanen H; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Hernberg M; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Mäkelä S; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Brück O; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Juteau S; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Kohtamäki L; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Haartmaninkatu 8, 00290, Helsinki, Finland.
  • Ilander M; Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
  • Mustjoki S; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Kreutzman A; Department of Pathology, Haartman Institute, University of Helsinki, Helsinki, Finland.
Cancer Immunol Immunother ; 69(5): 717-730, 2020 May.
Article em En | MEDLINE | ID: mdl-32036449
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Envelhecimento / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Melanoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Envelhecimento / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Melanoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article